The Valley Desk

NCT00807495 · Interventional trial

Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma

Overall registry status Completed

Phase 2

Conditions Burkitt's Lymphoma, Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, T-cell Lymphoma, Excluding Primary Cutaneous T-cell Lymphoma, Transformed Follicular Lymphoma With ≥ 50% Diffuse Large Cell Component

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov